no Starmel
     


Imunofit Junior

Imunofit Tablets












Bactoblis

Fields of activity

STARMEL® pharmaceuticals already bestirs itself in the promotion of medicines for the illnesses of the central nervous system such as schizophrenia, bipolar disease, depression, Alzheimer’ s disease and it is about to promote medicines which will cover the whole range of psychiatric and neurological illnesses.


From the summer of 2015,
STARMEL® pharmaceuticals had embarked on the promotion of medicines for pediatric, Cardiological, orthopedic, ophthalmic and dental illnesses.


Moreover,
STARMEL® pharmaceuticals, has intrigued the procedures of certification and launching in the Greek market not only for nutritional supplements but also for medicines which will reinforce the athletes overwrought organisms.


In the end of the first trimester of 2018,
STARMEL® pharmaceuticals will enter in the market of medical equipment and chemical products concerning the heath sector.